Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment? - Volk A; von Bülow C; Stern A; Simon R; Burandt E; Sauter G; Schmalfeldt B; Oliveira-Ferrer L (Journal of cancer research and clinical oncology, 2025)